scholarly journals Suicide and drug‐related mortality following occupational injury

2019 ◽  
Vol 62 (9) ◽  
pp. 733-741 ◽  
Author(s):  
Katie M. Applebaum ◽  
Abay Asfaw ◽  
Paul K. O'Leary ◽  
Andrew Busey ◽  
Yorghos Tripodis ◽  
...  
Keyword(s):  
Occupational Injury ◽  
Related Mortality

Workplace verbal abuse and risk of occupational injury among health care workers

2013 ◽  
Author(s):  
Erika L. Sabbath ◽  
Cassandra Okechukwu ◽  
David Hurtado ◽  
Glorian Sorensen
Keyword(s):  
Health Care ◽  
Health Care Workers ◽  
Occupational Injury ◽  
Verbal Abuse ◽  
Care Workers

Evaluation of R-CHOP and R-CVP in the treatment of elderly patient with non-Hodgkin lymphoma

MedPharmRes ◽  
2019 ◽  
Vol 3 (3) ◽  
pp. 1-6
Author(s):  
Truc Phan ◽  
Tram Huynh ◽  
Tuan Q. Tran ◽  
Dung Co ◽  
Khoi M. Tran
Keyword(s):  
Elderly Patients ◽  
Hodgkin Lymphoma ◽  
B Cell Lymphoma ◽  
Complete Response ◽  
The Elderly ◽  
Free Survival ◽  
Non Hodgkin Lymphoma ◽  
Common Sign ◽  
Related Mortality

Introduction: Little information is available on the outcomes of R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) and R-CVP (rituximab with cyclophosphamide, vincristine and prednisone) in treatment of the elderly patients with non-Hodgkin lymphoma (NHL), especially in Vietnam. Material and methods: All patients were newly diagnosed with CD20-positive non-Hodgkin lymphoma (NHL) at Blood Transfusion and Hematology Hospital, Ho Chi Minh city (BTH) between 01/2013 and 01/2018 who were age 60 years or older at diagnosis. A retrospective analysis of these patients was perfomed. Results: Twenty-one Vietnamese patients (6 males and 15 females) were identified and the median age was 68.9 (range 60-80). Most of patients have comorbidities and intermediate-risk. The most common sign was lymphadenopathy (over 95%). The proportion of diffuse large B cell lymphoma (DLBCL) was highest (71%). The percentage of patients reaching complete response (CR) after six cycle of chemotherapy was 76.2%. The median follow-up was 26 months, event-free survival (EFS) was 60% and overall survival (OS) was 75%. Adverse effects of rituximab were unremarkable, treatment-related mortality accounted for less than 10%. There was no difference in drug toxicity between two regimens. Conclusions: R-CHOP, R-CVP yielded a good result and acceptable toxicity in treatment of elderly patients with non-Hodgkin lymphoma. In patients with known cardiac history, omission of anthracyclines is reasonable and R-CVP provides a competitive complete response rate.

Gastrointestinal Ischemia Related Mortality in Patients Undergoing Off- or On-Pump Coronary Artery Bypass Grafting

2009 ◽  
Vol 12 (2) ◽  
pp. E79-E84 ◽  
Author(s):  
Mustafa Emmiler ◽  
Afsin Yaveri ◽  
Cevdet Uğur Koçoğullari ◽  
Yüksel Ela ◽  
Dursun Ali Şahin ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Coronary Artery Bypass ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Artery Bypass Grafting ◽  
Pump Coronary Artery Bypass ◽  
Gastrointestinal Ischemia ◽  
Related Mortality

Effects of Cancer, Coronary Artery Disease and other Comorbidities on COVID-19 Related Mortality: A Meta-analysis and Meta-regression

2020 ◽  
Vol 03 (04) ◽  
Author(s):  
Shon Shmushkevich ◽  
Massimo Baudo ◽  
Nagla Abdel Karim ◽  
Mahmoud Morsi ◽  
Mariam Khobsa ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Meta Analysis ◽  
Meta Regression ◽  
Artery Disease ◽  
Related Mortality
Sign in / Sign up

Export Citation Format

Share Document